3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
9
Neoplasms
7
Agnosia
5
Multiple Myeloma
4
Hodgkin Disease
4
Pain, Postoperative
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Cancer Pain
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Philadelphia Chromosome
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Acute Pain
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Interventions
Letrozole
4
Anastrozole
4
exemestane
2
Fatty Acids, Omega-3
2
Exercise
2
Aromatase Inhibitors
2
methyl hydroxyethyl cellulose
1
canakinumab
1
Yoga
1
Walking
1
Vitamin B 12
1
Therapeutics
1
Testosterone
1
Tamoxifen
1
Surveys and Questionnaires
1
Glucosamine
1
Glucaric Acid
1
Docosahexaenoic Acids
1
Diet Therapy
1
Chondroitin Sulfates
1
Chondroitin
1
Cholecalciferol
1
Cannabidiol
1
Calcium Gluconate
1
Calcium Citrate
1
Calcium Carbonate
1
Calcium
1
Acupuncture Therapy
1
Acupressure
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Arthralgia
×
Acetaminophen
×
Clear all
NCT04408560
2022-09-19
ARHOMA2
Institut Jean-Godinot
Phase NA
Completed
140 enrolled